Tesofensine20 mgTesofensine: nasal spray specifications
A nasal spray-format research material, listed with 20 mg per 10 mL bottle. Format terminology describes the supplied presentation and is not an instruction for administration.
- Listed compound(s): Tesofensine
- Listed total amount per bottle: 20 mg
- Fill volume: 10 mL
- Supplier-listed package output: 100 metered actuations
Formulation and documentation
The ReVitaCore Clinical Spray Catalog, Edition 01 (September 29, 2026), describes this spray range as using nano-encapsulation. This is a supplier-described formulation technology, not independent verification of this product’s performance. Confirm the full formulation, compound identity and lot specifications for your study.
Tesofensine is a small-molecule compound, not a peptide.
Request the current lot-specific certificate of analysis before laboratory use. A report for another compound, formulation or lot does not establish the specifications of this bottle. No lot-specific COA is attached to this new listing yet.
Supplier availability and dispatch timing require confirmation. This listing is available on backorder.
Read the research-format guide · Apply for a provider research account
For laboratory research only. Not for human or veterinary use, diagnosis, treatment, or disease prevention.
